KAREN CRAWFORD OSTERMAN: Open Payments
NPI 1245229285 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$411 in 17 payments from 13 companies in 2025. Trend: 2023 $94 · 2024 $106 · 2025 $411
Food & beverage: $411
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Janssen Biotech, Inc. | 1 | $42 |
| ABBVIE INC. | 2 | $42 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| Galderma Laboratories, L.P. | 1 | $38 |
| PFIZER INC. | 1 | $35 |
| UCB, Inc. | 1 | $30 |
| Incyte Corporation | 1 | $26 |
| Boston Scientific Corporation | 1 | $21 |
Products named: TREMFYA, DUPIXENT, NEMLUVIO, PREVNAR 20, Bimzelx, Rhapsido, OPZELURA, ILUMYA.
Industry payments across GA — which companies pay providers there.
